ondansetron has been researched along with Arthritis, Juvenile in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Arthritis, Juvenile: Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Rheumatoid arthritis, Methotrexate, Ondansetron, Nausea, Arthritis juvenile." | 4.12 | Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis. ( Fida, S; Kakalia, S; Khan, HA; Kitchlew, R; Saif, S; Siddique, M, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saif, S | 1 |
| Kakalia, S | 1 |
| Kitchlew, R | 1 |
| Khan, HA | 1 |
| Fida, S | 1 |
| Siddique, M | 1 |
1 other study available for ondansetron and Arthritis, Juvenile
| Article | Year |
|---|---|
Role of Ondansetron in Reducing Methotrexate Intolerance in Patients with Inflammatory Arthritis.
Topics: Antirheumatic Agents; Arthritis, Juvenile; Arthritis, Rheumatoid; Humans; Methotrexate; Nausea; Onda | 2022 |